This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Marc Martens
About me As co-head of our International Life Sciences & Healthcare group and head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels, I provide cutting edge strategic and regulatory advice to our life sciences clients and represent them in litigation.
6
Articles
0
Comments
Public Procurement for Biological Medicines in Belgium: The Royal Decree of 13 September 2023 opens the door for compulsory tendering when biosimilars enter the market. Can virtue afford to flirt with legality?
Introduction
The Royal Decree of September 13, 2023 (‘RD’), implementing Article 71bis, § 1,...
September 27, 2023
7 min read
European Commission proposes to change the rules on regulatory data protection for medicines
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
June 15, 2023
4 min read
Revamping the European pharmaceutical industry: A closer look at the EU’s proposed legislative framework
On 26 April 2023, the European Commission published the long-anticipated proposal for the revision of...
April 28, 2023
3 min read
Distribution of Free Samples of Medicinal Products to Pharmacists: The Court is requested to settle an Important Issue
The European and national legislations regulate the relationship between healthcare professionals and...
February 11, 2020
4 min read
Welcome to BioTalk!
BioTalk, is the new hub brought to you by Bird & Bird's International Life Sciences and Healthcare...
October 30, 2019
1 min read
The legal basis for Belgian biobanks enters into force
10 years after its first official publication, the legal framework on biobanks has entered into force...
December 11, 2018
3 min read